Assess whether to stop a model that increases alert volume without outcomes

SITUATION Mortality-and-morbidity reviewer in a rural hospital with long transfer times has one working extract — pediatric sepsis time-to-antibiotics chart — after a model vendor claiming AUC that the local validation cannot reproduce. If pediatric sepsis time-to-antibiotics chart cannot support to stop a model, the only defensible Healthcare output is hold.

DECISION Mortality-and-morbidity reviewer in a rural hospital with long transfer times must choose Proceed under protocol / Pause the pathway / Escalate safety review / Hold using pediatric sepsis time-to-antibiotics chart after a model vendor claiming AUC that the local validation cannot reproduce.

HYPOTHESES TO TEST 1. Authorize Proceed under protocol now; pediatric sepsis time-to-antibiotics chart already has the discriminator after a model vendor claiming AUC that the local validation cannot reproduce. 2. Keep Pause the pathway in force until pediatric sepsis time-to-antibiotics chart is completed after a model vendor claiming AUC that the local validation cannot reproduce for mortality-and-morbidity reviewer. 3. Treat pediatric sepsis time-to-antibiotics chart as Escalate safety review because both readings appear after a model vendor claiming AUC that the local validation cannot reproduce. 4. Refuse a Healthcare close: mortality-and-morbidity reviewer does not have the decision to stop a model turns on in pediatric sepsis time-to-antibiotics chart.

ANALYSIS REQUIRED 1. Assess patient-safety and HIPAA / minimum-necessary implications of to stop a model. 2. Quantify who is harmed if pediatric sepsis time-to-antibiotics chart is wrong. 3. Separate a documented exception from an OCR-relevant gap in a rural hospital with long transfer times. 4. For this Healthcare Outcomes Review file, read pediatric sepsis time-to-antibiotics chart against a model vendor claiming AUC that the local validation cannot reproduce and write the one fact that would move to stop a model for mortality-and-morbidity reviewer.

RECOMMENDATION Choose Proceed under protocol / Pause the pathway / Escalate safety review / Hold on this Healthcare / Outcomes Review packet (pediatric sepsis time-to-antibiotics chart after a model vendor claiming AUC that the local validation cannot reproduce). The follow-on Outcomes Review action is what mortality-and-morbidity reviewer does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line Healthcare option on to stop a model, then the evidence in pediatric sepsis time-to-antibiotics chart, then the action for mortality-and-morbidity reviewer - Hypothesis scorecard against pediatric sepsis time-to-antibiotics chart: supported / rejected / untestable - Owner and next date for mortality-and-morbidity reviewer in a rural hospital with long transfer times - What changes to stop a model if a model vendor claiming AUC that the local validation cannot reproduce is later withdrawn